World's Best Scientists 2026 revealed!
Massimo Triggiani

Massimo Triggiani

D-Index & Metrics

Immunology

D-Index
74
Citations
18289
World Ranking
2063
National Ranking
81

Massimo Triggiani publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Massimo Triggiani sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 331 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Massimo Triggiani D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Massimo Triggiani sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 74 D-Index — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Massimo Triggiani is affiliated with the University of Salerno in Italy and has contributed extensively to the fields of medicine and immunology. Their research spans multiple subfields including immunology, rheumatology, immunology and allergy, physiology, and pulmonary and respiratory medicine.

The scientist's work concentrates around key topics such as:

  • Mast cells and histamine
  • Asthma and respiratory diseases
  • Food allergy and anaphylaxis research
  • Urticaria and related conditions
  • Allergic rhinitis and sensitization
  • Eosinophilic disorders and syndromes
  • Eosinophilic esophagitis

Publications by Massimo Triggiani appear frequently in several specialized journals. Notable publication venues include:

  • The Journal of Allergy and Clinical Immunology In Practice
  • Journal of Allergy and Clinical Immunology
  • Clinical Lymphoma Myeloma & Leukemia
  • Allergy
  • International Journal of Molecular Sciences

Among recent papers they contributed to are:

  • "Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal" (2021), published in HemaSphere
  • "COVID 19: a clue from innate immunity" (2020), published in Immunologic Research
  • "Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts" (2020), published in Theranostics
  • "Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine" (2020), published in International Journal of Molecular Sciences
  • "Global Classification of Mast Cell Activation Disorders: An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium" (2022), published in The Journal of Allergy and Clinical Immunology In Practice

Massimo Triggiani has collaborated frequently with other researchers, including notable coauthors such as Karin Hartmann, Jason Gotlib, Patrizia Bonadonna, Iván Álvarez-Twöse, and Andreas Reiter. These collaborations have contributed to a body of work that intersects clinical and molecular aspects of allergic and immunologic conditions.

Best Publications

  • Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria.

    P. Valent;C. Akin;L. Escribano;M. Födinger

  • Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group

    Marco Cicardi;W. Aberer;A. Banerji;M. Bas

  • Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal

    Peter Valent;Cem Akin;Michel Arock;Knut Brockow

  • Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: Consensus report of an International Working Group

    M. Cicardi;K. Bork;T. Caballero;T. Craig

  • Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology

    Karin Hartmann;Luis Escribano;Clive Grattan;Knut Brockow

  • KIT mutation analysis in mast cell neoplasms : recommendations of the European Competence Network on Mastocytosis

    Michel Arock;Karl Sotlar;Cem Akin;Sigurd Broesby-Olsen

  • Control of arachidonate levels within inflammatory cells

    Floyd H. Chilton;Alfred N. Fonteh;Marc E. Surette;Massimo Triggiani

  • MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation

    J. Bousquet;H. J. Schunemann;J. Fonseca;B. Samolinski

  • Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal

    Peter Valent;Cem Akin;Karin Hartmann;Ivan Alvarez-Twose

  • Research needs in allergy: an EAACI position paper, in collaboration with EFA

    Nikolaos G Papadopoulos;Ioana Agache;Sevim Bavbek;Beatrice M Bilo

  • Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future

    Peter Valent;Cem Akin;Karin Hartmann;Gunnar Nilsson

  • Allergy and the cardiovascular system.

    M Triggiani;V Patella;R I Staiano;F Granata

  • Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects

    Aikaterini Detoraki;Rosaria I. Staiano;Francescopaolo Granata;Giorgio Giannattasio

  • MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

    Jean Bousquet;Holger J. Schünemann;Peter W. Hellings;Sylvie Arnavielhe

  • ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle

    J Bousquet;P W Hellings;I Agache;A Bedbrook

  • Integrated care pathways for airway diseases (AIRWAYS-ICPs).

    J. Bousquet;A. Addis;I. Adcock;I. Agache

  • International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency

    H Farkas;I Martinez-Saguer;K Bork;T Bowen

  • Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome.

    Peter Valent;Cem Akin;Patrizia Bonadonna;Karin Hartmann

  • Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin.

    Raffaele Cirillo;Massimo Triggiani;Lorenzo Siri;Anna Ciccarelli

  • Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis

    P Valent;L Escribano;S Broesby-Olsen;K Hartmann

  • Elevated serum sCD23 and sCD30 up to two decades prior to diagnosis associated with increased risk of non-Hodgkin lymphoma

    M P Purdue;Q Lan;T J Kemp;A Hildesheim

Frequent Co-Authors

Gianni Marone
Gianni Marone University of Naples Federico II
Karin Hartmann
Karin Hartmann University Hospital of Basel
Peter Valent
Peter Valent Medical University of Vienna
Knut Brockow
Knut Brockow Technical University of Munich
Patrizia Bonadonna
Patrizia Bonadonna University of Verona
Jason Gotlib
Jason Gotlib Stanford University
Pascal Demoly
Pascal Demoly University of Montpellier
Andreas Reiter
Andreas Reiter Heidelberg University
Jean Bousquet
Jean Bousquet University of Montpellier
Hanneke C. Kluin-Nelemans
Hanneke C. Kluin-Nelemans University Medical Center Groningen

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many professionals transition into immunology research or clinical roles by first establishing a strong foundation in nursing. Accelerated pathways, such as accelerated FNP programs, offer a fast track to becoming a Family Nurse Practitioner, blending clinical expertise with specialized knowledge useful in immunology-related fields.

Those without a nursing background can still quickly jump into healthcare through 12-month accelerated nursing programs online for non nurses. These programs provide essential skills swiftly, supporting career shifts towards immunology or patient care roles focused on immune system disorders.

For individuals seeking more accessible routes into nursing, it's helpful to consider the easiest accelerated nursing programs to get into. These programs balance admission criteria and program intensity to accommodate diverse learners aiming to contribute to immunology through nursing.

Additionally, starting with practical nursing through LPN schools easy to get into can be a stepping stone for hands-on experience in immune-related healthcare environments. This pathway often serves as the foundation for advancing into higher degrees and specialized immunology careers.

Best Scientists Citing Massimo Triggiani

Trending Scientists